Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Leader in Biomaterial expertise, Infinity BiologiX, increases global footprint and capabilities with expansion into Europe with key acquisition.

IBX, a global leader in biobanking, bioprocessing and analytics, has acquired UK based biospecimen storage specialists Roylance Pharma

Read the rest of entry »

Leaf Expression Systems Launch SupraVec the Next Generation in Plant-Based Expression Technology

NORWICH, UK – 07 September 2021: Leaf Expression Systems (Leaf), a biotechnology company specialising in plant-based expression, today announced the launch of SupraVecTM, Leaf’s new proprietary vector-based expression technology for the rapid production of proteins, vaccines and complex biomolecules within the leaf tissue of plants.

Read the rest of entry »

ARECOR SIGNS EXCLUSIVE FORMULATION COLLABORATION WITH INTAS PHARMACEUTICALS LTD

Cambridge, UK, 07 September 2021. Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that it has signed a formulation agreement with Intas Pharmaceuticals Ltd (“Intas”).

Read the rest of entry »

ARECOR ANNOUNCES APPOINTMENT OF GRANT THORNTON AS AUDITOR

Arecor Therapeutics plc (AIM: AREC), a globally focused biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that Grant Thornton UK LLP (“Grant Thornton”) have been appointed as the Group’s auditor, with immediate effect. Lakin Rose Limited has resigned as the auditor of Arecor Limited.

Read the rest of entry »

Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility

NOTTINGHAM, U.K.; Aug. 25, 2021 – Quotient Sciences, the drug development and manufacturing accelerator, announced a £6.3 million-pound investment in its recently acquired manufacturing facility in Alnwick, U.K. The investment will significantly expand Quotient’s drug substance manufacturing capability and will create 80 new jobs over the next three years.

Read the rest of entry »

Birmingham scientists discover new piece of clotting puzzle

Monday 23 August, 2021: Birmingham scientists have described a potential new target and strategy for anti-thrombotic therapy, in research that provides a new perspective on how blood clotting works in infectious and inflammatory diseases.  

Read the rest of entry »

AMSBIO: Biosimilar Products for Research Use

AMSBIO has launched a new range of research grade biosimilars that enable analysis of biological processes without the need to purchase expensive therapeutic-grade biologics.

Read the rest of entry »

AMSBIO: Highly efficient exosome isolation and purification tools

AMSBIO is a knowledgeable supplier of products dedicated to exosome research that includes high quality reagents and kits that are quick, affordable and easy to use. The latest addition to this portfolio is a new range of tools for isolating and purifying overall or specific exosome sub-populations from small volumes of sample in an efficient, faster and cheaper way. 

Read the rest of entry »

Fieldfisher advises Ultromics on $33 million Series B funding

International law firm Fieldfisher has advised UK headquartered medtech company Ultromics on its $33 million Series B funding round led by the Blue Venture Fund with participation from Optum Ventures, GV, and existing investor Oxford Sciences Innovation.

Read the rest of entry »

Insurance considerations when expanding into overseas territories

With the UK redoubling its R&D efforts in years to come and future trade agreements aiming to reduce barriers following Brexit, the opportunities to trade and export overseas are increasingly significant and exciting.

Read the rest of entry »

Pages: Previous1234567...36NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.